IL161105A0 - Estrogen/gestagen combination preparation and application thereof - Google Patents

Estrogen/gestagen combination preparation and application thereof

Info

Publication number
IL161105A0
IL161105A0 IL16110502A IL16110502A IL161105A0 IL 161105 A0 IL161105 A0 IL 161105A0 IL 16110502 A IL16110502 A IL 16110502A IL 16110502 A IL16110502 A IL 16110502A IL 161105 A0 IL161105 A0 IL 161105A0
Authority
IL
Israel
Prior art keywords
estrogen
application
combination preparation
gestagen combination
gestagen
Prior art date
Application number
IL16110502A
Other languages
English (en)
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IL161105A0 publication Critical patent/IL161105A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16110502A 2001-09-29 2002-09-25 Estrogen/gestagen combination preparation and application thereof IL161105A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01123511 2001-09-29
PCT/EP2002/010728 WO2003028735A1 (de) 2001-09-29 2002-09-25 Estrogen-gestagen kombinationspräparat und anwendung

Publications (1)

Publication Number Publication Date
IL161105A0 true IL161105A0 (en) 2004-08-31

Family

ID=8178810

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16110502A IL161105A0 (en) 2001-09-29 2002-09-25 Estrogen/gestagen combination preparation and application thereof

Country Status (16)

Country Link
US (1) US20040266745A1 (xx)
EP (1) EP1434586A1 (xx)
JP (1) JP2005507394A (xx)
KR (1) KR20040037097A (xx)
CN (1) CN1561217A (xx)
BR (1) BRPI0208558A2 (xx)
CA (1) CA2462075A1 (xx)
DE (1) DE10294402D2 (xx)
HU (1) HUP0402142A2 (xx)
IL (1) IL161105A0 (xx)
MX (1) MXPA04002771A (xx)
NO (1) NO20034159D0 (xx)
PL (1) PL373494A1 (xx)
RU (1) RU2004113305A (xx)
WO (1) WO2003028735A1 (xx)
ZA (1) ZA200402458B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
EP1761231A1 (en) * 2004-06-07 2007-03-14 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of dub
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
JP5675068B2 (ja) * 2009-07-13 2015-02-25 株式会社ミューチュアル 充填装置
EA021081B1 (ru) 2010-03-18 2015-03-31 Медкомб Холдинг Апс Одноразовая медицинская упаковка для фармацевтических композиций и способ ее изготовления
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2024124239A2 (en) * 2022-12-09 2024-06-13 Maple Mountain Group, Inc. Dietary supplement and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method

Also Published As

Publication number Publication date
MXPA04002771A (es) 2004-06-29
ZA200402458B (en) 2006-07-26
PL373494A1 (en) 2005-09-05
HUP0402142A2 (hu) 2005-02-28
EP1434586A1 (de) 2004-07-07
US20040266745A1 (en) 2004-12-30
KR20040037097A (ko) 2004-05-04
BRPI0208558A2 (pt) 2017-05-23
JP2005507394A (ja) 2005-03-17
WO2003028735A1 (de) 2003-04-10
CA2462075A1 (en) 2003-04-10
NO20034159L (no) 2003-09-18
RU2004113305A (ru) 2005-07-10
CN1561217A (zh) 2005-01-05
DE10294402D2 (de) 2004-11-11
NO20034159D0 (no) 2003-09-18

Similar Documents

Publication Publication Date Title
ZA200402458B (en) Estrogen/gestagen combination preparation and application thereof
HUP0400646A3 (en) Steroid hormone-compositions and processes for their preparation
AP2002002659A0 (en) 3-Nitrogen-6,7-dioxygen steroids and uses related thereto
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
AU2001294814A1 (en) Pumpcn compositions and uses thereof
EP1176948A4 (en) COMPOSITIONS AND METHODS
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001253179A1 (en) Defoamer compositions and uses therefor
HUP0301076A3 (en) Linezolid-crystal form ii and preparation thereof
AU2001273125A1 (en) Combinations of bisphosphonates, estrogenic agents and optionally estrogens
EP1385868A4 (en) STEROID DERIVATIVES
IL154553A0 (en) Urocortin-iii and uses thereof
EP1226154A4 (en) ÖSTRADIOL CONJUGATES AND ITS USE
IL154267A0 (en) Neuroprotective 2-pyridinamine compositions and related methods
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001240018A1 (en) Adeno-associated viral compositions and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
PL357020A1 (en) Pharmaceutical compositions containing steroidal structures and uses thereof
GB9922135D0 (en) Compositions and uses
IL165779A0 (en) Steroid conjugate, preparation thereof and the usethereof
AU2002350460A1 (en) Estrogen/gestagen combination preparation and application thereof
HUP0300387A3 (en) A glycopeptide and preparation thereof
GB2357692B (en) Preparation and combination tool